TP53 and amyotrophic lateral sclerosis: Surprisingly, inhibition of the p53 pathway displayed only a modest improvement on the survival of ALS MNs, suggesting that p53 activation may play a minor role in driving neurodegeneration in ALS (Figure 4A).